Form 8-K - Current report:
SEC Accession No. 0001193125-24-280112
Filing Date
2024-12-17
Accepted
2024-12-17 07:58:31
Documents
44
Period of Report
2024-12-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d883027d8k.htm   iXBRL 8-K 44832
2 EX-99.1 d883027dex991.htm EX-99.1 32381
3 EX-99.2 d883027dex992.htm EX-99.2 38715
7 GRAPHIC g883027dsp6.jpg GRAPHIC 11915
8 GRAPHIC g883027g10g10.jpg GRAPHIC 249426
9 GRAPHIC g883027g11g11.jpg GRAPHIC 97303
10 GRAPHIC g883027g12g12.jpg GRAPHIC 256155
11 GRAPHIC g883027g13g13.jpg GRAPHIC 99408
12 GRAPHIC g883027g14g14.jpg GRAPHIC 162153
13 GRAPHIC g883027g15g15.jpg GRAPHIC 227017
14 GRAPHIC g883027g16g16.jpg GRAPHIC 179841
15 GRAPHIC g883027g17g17.jpg GRAPHIC 215407
16 GRAPHIC g883027g18g18.jpg GRAPHIC 178448
17 GRAPHIC g883027g19g19.jpg GRAPHIC 168705
18 GRAPHIC g883027g20g20.jpg GRAPHIC 205409
19 GRAPHIC g883027g21g21.jpg GRAPHIC 207611
20 GRAPHIC g883027g22g22.jpg GRAPHIC 99860
21 GRAPHIC g883027g23g23.jpg GRAPHIC 71295
22 GRAPHIC g883027g24g24.jpg GRAPHIC 183271
23 GRAPHIC g883027g25g25.jpg GRAPHIC 168510
24 GRAPHIC g883027g26g26.jpg GRAPHIC 147588
25 GRAPHIC g883027g27g27.jpg GRAPHIC 205198
26 GRAPHIC g883027g28g28.jpg GRAPHIC 211641
27 GRAPHIC g883027g29g29.jpg GRAPHIC 241636
28 GRAPHIC g883027g30g30.jpg GRAPHIC 171440
29 GRAPHIC g883027g31g31.jpg GRAPHIC 187421
30 GRAPHIC g883027g32g32.jpg GRAPHIC 146595
31 GRAPHIC g883027g33g33.jpg GRAPHIC 162154
32 GRAPHIC g883027g34g34.jpg GRAPHIC 101357
33 GRAPHIC g883027g35g35.jpg GRAPHIC 218411
34 GRAPHIC g883027g36g36.jpg GRAPHIC 162007
35 GRAPHIC g883027g37g37.jpg GRAPHIC 161408
  Complete submission text file 0001193125-24-280112.txt   7017356

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tnya-20241217.xsd EX-101.SCH 2884
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tnya-20241217_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tnya-20241217_pre.xml EX-101.PRE 11730
46 EXTRACTED XBRL INSTANCE DOCUMENT d883027d8k_htm.xml XML 3789
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40656 | Film No.: 241553678
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)